KR100549355B1 - 시메티콘/인산칼슘무수물조성물 - Google Patents
시메티콘/인산칼슘무수물조성물 Download PDFInfo
- Publication number
- KR100549355B1 KR100549355B1 KR1019980028787A KR19980028787A KR100549355B1 KR 100549355 B1 KR100549355 B1 KR 100549355B1 KR 1019980028787 A KR1019980028787 A KR 1019980028787A KR 19980028787 A KR19980028787 A KR 19980028787A KR 100549355 B1 KR100549355 B1 KR 100549355B1
- Authority
- KR
- South Korea
- Prior art keywords
- simethicone
- calcium phosphate
- granular
- phosphate anhydride
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
성 분 | 양(㎎/정제) |
Ⅰ 부분-농축물 | |
3염기성 인산칼슘, NF, 무수, 과립 | 500 |
시메티콘, USP | 125 |
3염기성 인산칼슘, NF, 무수, 분말 | 25 |
Ⅱ 부분-스캐빈저 | |
3염기성 인산칼슘, NF, 무수, 분말 | 20 |
Ⅲ 부분-부형제/결합제 시스템 | |
2염기성 인산칼슘, 이수화물, USP | 105.75 |
미세결정상 셀룰로오즈, NF(MCC) | 53 |
결정상 소르비톨, NF | 70 |
크로스카르멜롤오즈 나트륨, NF | 30 |
Ⅳ 부분-윤활제 | |
마그네슘 스테아레이트, NF | 0.5 |
Claims (13)
- 시메티콘(a)과 과립상의 3염기성 또는 2염기성 인산칼슘 무수물 또는 이의 혼합물(b)을 포함하고,시메티콘/인산칼슘 혼합물이 입자 크기가 1000㎛ 이하인 균일한 과립상 조성물인 자유 유동성 과립상 조성물.
- 제1항에 있어서, 과립상 혼합물 조성물을 구성하는 성분들의 비율이 시메티콘 10 내지 70중량%와 과립상의 3염기성 또는 2염기성 인산칼슘 무수물 30 내지 90중량%인 자유 유동성 과립상 조성물.
- 제1항 또는 제2항에 있어서, 이산화규소를 0.5 내지 4중량%의 양으로 또는 인산칼슘 무수물 분말을 1 내지 30중량%의 양으로 추가로 포함하는 자유 유동성 과립상 조성물.
- 제1항에 따르는 자유 유동성 과립상 조성물로부터 형성된 소포용 시메티콘의 고체상 경구 투여형 제제.
- 제4항에 있어서, 연하성 또는 저작성 단위 용량의 압축 정제, 또는 캐플릿, 젤캡, 캡슐, 로젠지 또는 신속 용해성 웨이퍼 형태인 고체상 경구 투여형 제제.
- 제4항에 있어서, 자유 유동성 과립상 조성물 이외에 하나 이상의 부형제를 추가로 포함하는 고체상 경구 투여형 제제.
- 제6항에 있어서, 부형제가 하나 이상의 충전제, 결합제, 감미제, 인공 감미제, 윤활제, 활탁제, 붕해제, 착색제, 흡착제, 산성화제 및 향미제로부터 선택되는 고체상 경구 투여형 제제.
- 제4항 내지 제7항 중의 어느 한 항에 있어서, 시메티콘 함량이 8 내지 20중량%인 고체상 경구 투여형 제제.
- 제4항 내지 제7항 중의 어느 한 항에 있어서, 시메티콘과 과립상의 3염기성 또는 2염기성 인산칼슘 무수물을 포함하는 자유 유동성 과립상 조성물 이외에, 결정상 소르비톨, 미세결정상 셀룰로오즈 및 3염기성 또는 2염기성 인산칼슘 무수물을 부형제로서 추가로 포함하는 고체상 경구 투여형 제제.
- 제4항 내지 제7항 중의 어느 한 항에 있어서, 위장 장애의 치료에 적합한 부가적 활성 성분 하나 이상을 추가로 포함하는 고체상 경구 투여형 제제.
- 제10항에 있어서, 부가적 활성 성분이 H2 수용체 길항제, 양성자 펌프 억제제, 설사 억제제, 위장 운동제 및 제산제 중의 하나 이상으로부터 선택되는 고체상 경구 투여형 제제.
- 시메티콘을 과립상의 3염기성 또는 2염기성 인산칼슘 무수물에 가하고, 균일해질 때까지 건식 블렌딩한 다음, 자유 유동성의 균일한 과립상 조성물을 확보하기 위해 전단시키는 단계를 포함하는, 고체상 경구 투여형 제제로 압축하기 위한 시메티콘 소포제를 포함하는 자유 유동성 과립상 조성물의 제조방법.
- 제12항에 있어서, 시메티콘을 과립상의 3염기성 또는 2염기성 인산칼슘 무수물 및 스캐빈저로서 이산화규소 또는 인산칼슘 무수물 분말에 가하여 시메티콘, 과립상의 3염기성 또는 2염기성 인산칼슘 무수물 및 이산화규소 또는 인산칼슘 무수물 분말을 포함하는 혼합물이 형성되는 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/896,189 | 1997-07-17 | ||
US08/896,189 US6103260A (en) | 1997-07-17 | 1997-07-17 | Simethicone/anhydrous calcium phosphate compositions |
US8/896,189 | 1997-07-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR19990013918A KR19990013918A (ko) | 1999-02-25 |
KR100549355B1 true KR100549355B1 (ko) | 2006-04-06 |
Family
ID=25405781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980028787A KR100549355B1 (ko) | 1997-07-17 | 1998-07-16 | 시메티콘/인산칼슘무수물조성물 |
Country Status (19)
Country | Link |
---|---|
US (1) | US6103260A (ko) |
EP (1) | EP0891776B1 (ko) |
JP (1) | JPH1192387A (ko) |
KR (1) | KR100549355B1 (ko) |
CN (1) | CN1267106C (ko) |
AR (1) | AR013227A1 (ko) |
AT (1) | ATE259236T1 (ko) |
AU (1) | AU727271B2 (ko) |
BR (1) | BR9802487B1 (ko) |
CZ (1) | CZ294084B6 (ko) |
DE (1) | DE69821553T2 (ko) |
DK (1) | DK0891776T3 (ko) |
ES (1) | ES2216244T3 (ko) |
HU (1) | HUP9801615A3 (ko) |
NZ (1) | NZ330915A (ko) |
PL (1) | PL189988B1 (ko) |
PT (1) | PT891776E (ko) |
RU (1) | RU2216317C2 (ko) |
ZA (1) | ZA986338B (ko) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326384B1 (en) * | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6793934B1 (en) * | 1999-12-08 | 2004-09-21 | Shire Laboratories, Inc. | Solid oral dosage form |
KR100442174B1 (ko) * | 2001-09-25 | 2004-07-30 | (주)다산메디켐 | 이산화규소, 폴리소르베이트류 및디메칠폴리실록산(디메치콘, 시메치콘)을 함유하는소화기장애에 사용되는 고형의 신규의약조성물 |
US20040253312A1 (en) | 2001-09-28 | 2004-12-16 | Sowden Harry S. | Immediate release dosage form comprising shell having openings therein |
US7122143B2 (en) | 2001-09-28 | 2006-10-17 | Mcneil-Ppc, Inc. | Methods for manufacturing dosage forms |
US20040146559A1 (en) * | 2002-09-28 | 2004-07-29 | Sowden Harry S. | Dosage forms having an inner core and outer shell with different shapes |
CN1638740A (zh) * | 2001-09-28 | 2005-07-13 | 麦克内尔-Ppc股份有限公司 | 释出得到修饰的剂型 |
US20030229158A1 (en) * | 2001-09-28 | 2003-12-11 | Chen Jen Chi | Polymer composition and dosage forms comprising the same |
US6837696B2 (en) * | 2001-09-28 | 2005-01-04 | Mcneil-Ppc, Inc. | Apparatus for manufacturing dosage forms |
US7101573B2 (en) * | 2001-09-28 | 2006-09-05 | Mcneil-Pcc, Inc. | Simethicone solid oral dosage form |
US7838026B2 (en) | 2001-09-28 | 2010-11-23 | Mcneil-Ppc, Inc. | Burst-release polymer composition and dosage forms comprising the same |
US6753009B2 (en) | 2002-03-13 | 2004-06-22 | Mcneil-Ppc, Inc. | Soft tablet containing high molecular weight polyethylene oxide |
US7169450B2 (en) * | 2002-05-15 | 2007-01-30 | Mcneil-Ppc, Inc. | Enrobed core |
US7807197B2 (en) * | 2002-09-28 | 2010-10-05 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
NZ538842A (en) | 2002-09-28 | 2008-03-28 | Mcneil Ppc Inc | Immediate release dosage form comprising a solid core of density 0.9 g/ml surrounded by a shell that is readily soluble to gastrointestinal fluids |
US7341742B2 (en) * | 2002-09-30 | 2008-03-11 | L. Perrigo Company | Simethicone containing tablet composition and method |
US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
TWI327913B (en) * | 2003-03-12 | 2010-08-01 | Novartis Ag | Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid |
US20040185093A1 (en) * | 2003-03-18 | 2004-09-23 | Szymczak Christopher E. | Compositions containing sucralose |
US20040186180A1 (en) * | 2003-03-21 | 2004-09-23 | Gelotte Cathy K. | Non-steroidal anti-inflammatory drug dosing regimen |
US20040265373A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
US20040265372A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
US20050069590A1 (en) * | 2003-09-30 | 2005-03-31 | Buehler Gail K. | Stable suspensions for medicinal dosages |
US20050074514A1 (en) * | 2003-10-02 | 2005-04-07 | Anderson Oliver B. | Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms |
US20050095299A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
US20050095300A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
US7879354B2 (en) | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
US8067029B2 (en) | 2004-01-13 | 2011-11-29 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
US20050196447A1 (en) * | 2004-03-05 | 2005-09-08 | Huang Hai Y. | Polymeric compositions and dosage forms comprising the same |
US20050196446A1 (en) * | 2004-03-05 | 2005-09-08 | Huang Hai Y. | Polymeric compositions and dosage forms comprising the same |
US20050196448A1 (en) * | 2004-03-05 | 2005-09-08 | Hai Yong Huang | Polymeric compositions and dosage forms comprising the same |
US20050196442A1 (en) * | 2004-03-05 | 2005-09-08 | Huang Hai Y. | Polymeric compositions and dosage forms comprising the same |
US20060046998A1 (en) * | 2004-08-25 | 2006-03-02 | Fairfield Clinical Trials, Llc | Method of treatment of gastroesophageal reflux disease and laryngopharyngeal reflux disease |
US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
US20060088593A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20070281022A1 (en) * | 2004-10-27 | 2007-12-06 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US8383159B2 (en) * | 2004-10-27 | 2013-02-26 | Mcneil-Ppc, Inc. | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20070190133A1 (en) * | 2004-10-27 | 2007-08-16 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060088587A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060088586A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060087051A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
CO5790164A1 (es) * | 2006-08-10 | 2007-08-31 | Procaps S A | Composicion farmaceutica solida que incluye en combinacion un agente regulador de la motilidad intestinal y un agente antiflatulento |
EP3292866B1 (en) | 2006-10-20 | 2023-07-26 | Johnson & Johnson Consumer Inc. | Acetaminophen / ibuprofen combinations |
US20080113021A1 (en) * | 2006-10-25 | 2008-05-15 | Robert Shen | Ibuprofen composition |
JP2010510320A (ja) | 2006-11-21 | 2010-04-02 | マクニール−ピーピーシー・インコーポレーテツド | 改変型放出鎮痛性懸濁液 |
US8491937B2 (en) * | 2007-02-15 | 2013-07-23 | Wyeth Llc | Stability in vitamin and mineral supplements |
US9833510B2 (en) * | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
US20090004248A1 (en) * | 2007-06-29 | 2009-01-01 | Frank Bunick | Dual portion dosage lozenge form |
US20090060983A1 (en) * | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
AU2008302460A1 (en) * | 2007-09-17 | 2009-03-26 | Mcneil-Ppc, Inc. | Dip coated compositions containing copolymer of polyvinyl alcohol and polyethylene glycol and a gum |
ES2633449T3 (es) * | 2007-10-31 | 2017-09-21 | Johnson & Johnson Consumer Inc. | Forma de dosis oralmente desintegrable |
US8357395B2 (en) * | 2007-12-21 | 2013-01-22 | Mcneil-Ppc, Inc. | Manufacture of tablet |
CA2711974A1 (en) * | 2008-01-31 | 2009-08-13 | Mcneil-Ppc, Inc. | Edible film-strips with modified release active ingredients |
EP2244699A2 (en) * | 2008-01-31 | 2010-11-03 | Mcneil-PPC, Inc | Edible film-strips for immediate release of active ingredients |
EP2252271B1 (en) * | 2008-02-19 | 2012-05-23 | McNeil-PPC, Inc. | Dip coated compositions containing a starch having a high amylose content |
CN102119027A (zh) * | 2008-06-26 | 2011-07-06 | 麦克内尔-Ppc股份有限公司 | 含有药物活性剂的包衣颗粒 |
EP2310075A2 (en) | 2008-07-08 | 2011-04-20 | Hyperbranch Medical Technology, Inc. | Self-contained medical applicators for multiple component formulations, and methods of use thereof |
EP2364143A1 (en) * | 2008-10-31 | 2011-09-14 | McNeil-PPC, Inc. | Osmotic tablet with a compressed outer coating |
US20100247586A1 (en) * | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
BRPI1016013A2 (pt) | 2009-06-29 | 2016-04-26 | Mcneil Ppc Inc | tablete farmacêutico contendo uma cápsula preenchida com líquido. |
US8871263B2 (en) | 2009-09-24 | 2014-10-28 | Mcneil-Ppc, Inc. | Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
US8313768B2 (en) | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
WO2012039788A1 (en) | 2010-09-22 | 2012-03-29 | Mcneil-Ppc, Inc. | Multi-layered orally disintegrating tablet and the manufacture thereof |
US20110318411A1 (en) | 2010-06-24 | 2011-12-29 | Luber Joseph R | Multi-layered orally disintegrating tablet and the manufacture thereof |
US20110070286A1 (en) * | 2009-09-24 | 2011-03-24 | Andreas Hugerth | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
TWI461213B (zh) * | 2009-11-05 | 2014-11-21 | Fmc Corp | 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物 |
BR112013006689A2 (pt) | 2010-09-22 | 2016-06-07 | Mcneil Ppc Inc | fabricação de tabletes a partir de blenda de pós com energia aplicada |
MX2010012479A (es) * | 2010-11-16 | 2012-05-16 | Posi Visionary Solutions Llp | Composicion farmaceutica de administracion oral para el tratamiento del sindrome de intestino irritable, a base de un modificador de la motilidad intestinal, un agente que previene la retencion de gases y enzimas digestivas y proceso para su preparacion. |
IN2014MN01382A (ko) | 2011-12-14 | 2015-04-17 | Disphar Int Bv | |
MX359529B (es) | 2012-02-07 | 2018-10-01 | Mcneil Ppc Inc | Tabletas recubiertas de desintegración rápida. |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
US20130295174A1 (en) | 2012-05-01 | 2013-11-07 | Mcneil-Ppc, Inc. | Tablet comprising a first and second region |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
GB201315558D0 (en) | 2013-08-02 | 2013-10-16 | Tate & Lyle Ingredients | Sweetener compositions |
GB201315559D0 (en) * | 2013-08-02 | 2013-10-16 | Tate & Lyle Ingredients | Sweetener compositions |
WO2015105992A1 (en) | 2014-01-10 | 2015-07-16 | Mcneil-Ppc, Inc. | Process for making tablet using radiofrequency and lossy coated particles |
EP3102564A4 (en) | 2014-02-05 | 2017-10-18 | Merck Sharp & Dohme Corp. | Tablet formulation for cgrp-active compounds |
WO2016114734A1 (en) | 2015-01-16 | 2016-07-21 | Biofarma Ilaç Sanayi Ve Ticaret A. Ş. | Pharmaceutical formulation of trimebutine maleate and simethicone comprising acidifying agent |
MA41620A (fr) | 2015-05-14 | 2018-01-09 | Abdi Ibrahim Ilac Sanayi Ve Ticaret A S | Composition pharmaceutique comprenant de la siméthicone et de l'otilonium |
WO2016200345A1 (en) | 2015-06-12 | 2016-12-15 | Santa Farma İlaç Sanayi̇ A. Ş. | Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics. |
CA3031474A1 (en) | 2016-07-19 | 2018-01-25 | Johnson & Johnson Consumer Inc. | Tablets having discontinuous coated regions |
US10583089B2 (en) | 2016-07-19 | 2020-03-10 | Johnson & Johnson Consumer Inc. | Tablets having discontinuous coated regions |
EP3544631A1 (en) | 2016-11-28 | 2019-10-02 | Johnson & Johnson Consumer Inc. | Liquid compositions comprising a mucoadhesive agent |
EP3544585A1 (en) | 2016-11-28 | 2019-10-02 | Johnson & Johnson Consumer Inc. | Process for making a coated dosage form |
MX2016016587A (es) * | 2016-12-14 | 2018-06-13 | Rhein Siegfried Sa De Cv | Composicion mejorada de lansoprazol y simeticona y procesos para prepararla. |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
EP3634387B1 (en) | 2017-05-22 | 2024-01-17 | Johnson & Johnson Consumer Inc. | Lozenge dosage form |
CN107573689A (zh) * | 2017-08-03 | 2018-01-12 | 江苏汉斯通药业有限公司 | 西甲硅油的制备方法 |
WO2019064112A1 (en) * | 2017-09-29 | 2019-04-04 | Johnson & Johnson Consumer Inc. | SOLID PARTICLES OF SIMETHICONE AND THEIR DOSAGE FORM |
CN111629714A (zh) | 2018-01-22 | 2020-09-04 | 强生消费者公司 | 打孔胶囊 |
MX2023007575A (es) | 2020-12-22 | 2023-09-21 | Allergan Pharmaceuticals Int Ltd | Tratamiento de la migraña. |
WO2023089432A1 (en) | 2021-11-16 | 2023-05-25 | Johnson & Johnson Consumer Inc. | Customizable dosage forms containing simethicone |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0465234A1 (en) * | 1990-07-03 | 1992-01-08 | McNEIL-PPC, INC. | Pharmaceutical compositions and methods for alleviating gastrointestinal distress symptoms induced by nonsteroidal anti-inflammatory drugs |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE25205E (en) * | 1960-10-10 | 1962-07-24 | Silicone composition for the relief of | |
US4127650A (en) * | 1975-03-31 | 1978-11-28 | William H. Rorer, Inc. | Medicinal simethicone containing composition and its method of production |
US4396604A (en) * | 1982-05-17 | 1983-08-02 | Norcliff Thayer, Inc. | Simethicone antacid lozenge |
US4557916A (en) * | 1984-10-22 | 1985-12-10 | J. M. Huber Corporation | Synthetic calcium silicates and methods of preparation |
US4867989A (en) * | 1986-09-09 | 1989-09-19 | Warner-Lambert Company | Chewing gum mineral supplement |
US4906478A (en) * | 1988-12-12 | 1990-03-06 | Valentine Enterprises, Inc. | Simethicone/calcium silicate composition |
US5275822A (en) * | 1989-10-19 | 1994-01-04 | Valentine Enterprises, Inc. | Defoaming composition |
US5073384A (en) * | 1989-10-19 | 1991-12-17 | Valentine Enterprises, Inc. | Maltodextrin/defoaming composition combinate |
GR1002332B (el) * | 1992-05-21 | 1996-05-16 | Mcneil-Ppc Inc. | Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. |
FR2705966B1 (fr) * | 1993-06-04 | 1995-08-25 | Dow Corning Sa | Compositions antimousse utiles notamment pour le traitement de troubles gastriques. |
-
1997
- 1997-07-17 US US08/896,189 patent/US6103260A/en not_active Expired - Lifetime
-
1998
- 1998-07-07 NZ NZ330915A patent/NZ330915A/xx not_active IP Right Cessation
- 1998-07-09 AU AU75088/98A patent/AU727271B2/en not_active Ceased
- 1998-07-14 JP JP10213446A patent/JPH1192387A/ja active Pending
- 1998-07-15 CZ CZ19982221A patent/CZ294084B6/cs not_active IP Right Cessation
- 1998-07-15 PL PL98327491A patent/PL189988B1/pl unknown
- 1998-07-16 HU HU9801615A patent/HUP9801615A3/hu unknown
- 1998-07-16 DK DK98305696T patent/DK0891776T3/da active
- 1998-07-16 AR ARP980103484A patent/AR013227A1/es active IP Right Grant
- 1998-07-16 EP EP98305696A patent/EP0891776B1/en not_active Expired - Lifetime
- 1998-07-16 RU RU98114678/14A patent/RU2216317C2/ru active
- 1998-07-16 DE DE69821553T patent/DE69821553T2/de not_active Expired - Lifetime
- 1998-07-16 PT PT98305696T patent/PT891776E/pt unknown
- 1998-07-16 AT AT98305696T patent/ATE259236T1/de not_active IP Right Cessation
- 1998-07-16 KR KR1019980028787A patent/KR100549355B1/ko not_active IP Right Cessation
- 1998-07-16 ZA ZA9806338A patent/ZA986338B/xx unknown
- 1998-07-16 BR BRPI9802487-6A patent/BR9802487B1/pt not_active IP Right Cessation
- 1998-07-16 ES ES98305696T patent/ES2216244T3/es not_active Expired - Lifetime
- 1998-07-17 CN CNB981175988A patent/CN1267106C/zh not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0465234A1 (en) * | 1990-07-03 | 1992-01-08 | McNEIL-PPC, INC. | Pharmaceutical compositions and methods for alleviating gastrointestinal distress symptoms induced by nonsteroidal anti-inflammatory drugs |
Also Published As
Publication number | Publication date |
---|---|
EP0891776A1 (en) | 1999-01-20 |
ZA986338B (en) | 2000-01-17 |
DE69821553T2 (de) | 2004-12-23 |
CZ294084B6 (cs) | 2004-10-13 |
ES2216244T3 (es) | 2004-10-16 |
AU7508898A (en) | 1999-01-28 |
KR19990013918A (ko) | 1999-02-25 |
HU9801615D0 (en) | 1998-09-28 |
EP0891776B1 (en) | 2004-02-11 |
RU2216317C2 (ru) | 2003-11-20 |
AR013227A1 (es) | 2000-12-13 |
ATE259236T1 (de) | 2004-02-15 |
JPH1192387A (ja) | 1999-04-06 |
HUP9801615A3 (en) | 2000-06-28 |
PT891776E (pt) | 2004-05-31 |
BR9802487A (pt) | 1999-09-08 |
US6103260A (en) | 2000-08-15 |
DK0891776T3 (da) | 2004-05-10 |
CZ222198A3 (cs) | 1999-02-17 |
DE69821553D1 (de) | 2004-03-18 |
AU727271B2 (en) | 2000-12-07 |
BR9802487B1 (pt) | 2010-05-18 |
CN1207898A (zh) | 1999-02-17 |
NZ330915A (en) | 1999-06-29 |
PL327491A1 (en) | 1999-01-18 |
HUP9801615A2 (hu) | 1999-07-28 |
PL189988B1 (pl) | 2005-10-31 |
CN1267106C (zh) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100549355B1 (ko) | 시메티콘/인산칼슘무수물조성물 | |
EP0664697B1 (en) | Ranitidine chewable tablets | |
EP0273209B1 (en) | Composition of matter containing polycarbophil | |
EP1128815B1 (en) | Process for preparing oral calcium compositions | |
EP0557065B1 (en) | Spheroid formulation | |
KR100258223B1 (ko) | 신속 용해형 정제 및 그의 제조법 | |
AU712464B2 (en) | Improvements in or relating to organic compositions | |
EP1086701B1 (en) | Simethicone containing laxative composition | |
KR100373393B1 (ko) | 단위생약제제로서의타블랫형비타민과칼슘복합치료제제와이의제조방법및용도 | |
CZ299145B6 (cs) | Rychle se rozpouštející farmaceutická dávková forma pro perorální podání, zpusob její výroby a zpusob výroby granulí vhodných pro její výrobu | |
KR20130030306A (ko) | 약학 조성물 | |
WO2008056200A1 (en) | Oral pharmaceutical compositions of simethicone | |
US6589507B1 (en) | Foaming antacid suspension tablets | |
JP2002501015A (ja) | リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品 | |
PL210931B1 (pl) | Kompozycja w postaci stałej nadająca się do połykania zawierająca alginian, wodorowęglan i/lub węglan, jej zastosowanie oraz sposób wytwarzania | |
EP0599767B1 (en) | Process to prepare water-dispersable tablets containing diclofenac | |
US20060034911A1 (en) | New oral immediated release dosage form | |
MXPA98005755A (en) | Simethicone/anhydrous calcium phosphate compositions | |
JPH06504038A (ja) | 有効な固形非ロゼンジ制酸/抗ガス薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130107 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140103 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20141230 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160104 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170102 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180103 Year of fee payment: 13 |
|
EXPY | Expiration of term |